Literature DB >> 11340171

c-Myc is a critical target for c/EBPalpha in granulopoiesis.

L M Johansen1, A Iwama, T A Lodie, K Sasaki, D W Felsher, T R Golub, D G Tenen.   

Abstract

CCAAT/enhancer binding protein alpha (C/EBPalpha) is an integral factor in the granulocytic developmental pathway, as myeloblasts from C/EBPalpha-null mice exhibit an early block in differentiation. Since mice deficient for known C/EBPalpha target genes do not exhibit the same block in granulocyte maturation, we sought to identify additional C/EBPalpha target genes essential for myeloid cell development. To identify such genes, we used both representational difference analysis and oligonucleotide array analysis with RNA derived from a C/EBPalpha-inducible myeloid cell line. From each of these independent screens, we identified c-Myc as a C/EBPalpha negatively regulated gene. We mapped an E2F binding site in the c-Myc promoter as the cis-acting element critical for C/EBPalpha negative regulation. The identification of c-Myc as a C/EBPalpha target gene is intriguing, as it has been previously shown that down-regulation of c-Myc can induce myeloid differentiation. Here we show that stable expression of c-Myc from an exogenous promoter not responsive to C/EBPalpha-mediated down-regulation forces myeloblasts to remain in an undifferentiated state. Therefore, C/EBPalpha negative regulation of c-Myc is critical for allowing early myeloid precursors to enter a differentiation pathway. This is the first report to demonstrate that C/EBPalpha directly affects the level of c-Myc expression and, thus, the decision of myeloid blasts to enter into the granulocytic differentiation pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11340171      PMCID: PMC87031          DOI: 10.1128/MCB.21.11.3789-3806.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  75 in total

Review 1.  The transcriptional control of hematopoiesis.

Authors:  R A Shivdasani; S H Orkin
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

2.  DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family.

Authors:  S Osada; H Yamamoto; T Nishihara; M Imagawa
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

3.  A novel function for Myc: inhibition of C/EBP-dependent gene activation.

Authors:  S Mink; B Mutschler; R Weiskirchen; K Bister; K H Klempnauer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  The role of p16 in the E2F-dependent thymidine kinase regulation.

Authors:  M Hengstschläger; E Hengstschläger-Ottnad; O Pusch; E Wawra
Journal:  Oncogene       Date:  1996-04-18       Impact factor: 9.867

5.  Regulation of the cyclin E gene by transcription factor E2F1.

Authors:  K Ohtani; J DeGregori; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

Review 6.  Introduction to the E2F family: protein structure and gene regulation.

Authors:  J E Slansky; P J Farnham
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

7.  Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein.

Authors:  P J Watkins; J P Condreay; B E Huber; S J Jacobs; D J Adams
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

8.  CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein.

Authors:  N A Timchenko; M Wilde; M Nakanishi; J R Smith; G J Darlington
Journal:  Genes Dev       Date:  1996-04-01       Impact factor: 11.361

9.  Myc inhibits CCAAT/enhancer-binding protein alpha-gene expression in HIB-1B hibernoma cells through interactions with the core promoter region.

Authors:  P Antonson; M G Pray; A Jacobsson; K G Xanthopoulos
Journal:  Eur J Biochem       Date:  1995-09-01

10.  Extending dimerization interfaces: the bZIP basic region can form a coiled coil.

Authors:  D Krylov; M Olive; C Vinson
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

View more
  97 in total

1.  The identification of E2F1-specific target genes.

Authors:  Julie Wells; Carrie R Graveel; Stephanie M Bartley; Steven J Madore; Peggy J Farnham
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Use of chromatin immunoprecipitation to clone novel E2F target promoters.

Authors:  A S Weinmann; S M Bartley; T Zhang; M Q Zhang; P J Farnham
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

3.  DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.

Authors:  Mirko Marabese; Faina Vikhanskaya; Cristina Rainelli; Toshiyuki Sakai; Massimo Broggini
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

Review 4.  Transcriptional regulation of myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

Review 5.  Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.

Authors:  Steffen Koschmieder; Frank Rosenbauer; Ulrich Steidl; Bronwyn M Owens; Daniel G Tenen
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

Review 6.  C/EBPα deregulation as a paradigm for leukemogenesis.

Authors:  J A Pulikkan; D G Tenen; G Behre
Journal:  Leukemia       Date:  2017-07-19       Impact factor: 11.528

Review 7.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

8.  C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.

Authors:  Thomas Sebastian; Radek Malik; Sara Thomas; Julien Sage; Peter Frederick Johnson
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

9.  High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.

Authors:  Ji Suk Chang; Ramasamy Santhanam; Rossana Trotta; Paolo Neviani; Anna M Eiring; Edward Briercheck; Mattia Ronchetti; Denis C Roy; Bruno Calabretta; Michael A Caligiuri; Danilo Perrotti
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

10.  GATA-1-mediated proliferation arrest during erythroid maturation.

Authors:  Marcin Rylski; John J Welch; Ying-Yu Chen; Danielle L Letting; J Alan Diehl; Lewis A Chodosh; Gerd A Blobel; Mitchell J Weiss
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.